ChartMill assigns a Buy % Consensus number of 73% to RGLS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-01 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-04-30 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-04-30 | Jones Trading | Downgrade | Buy -> Hold |
| 2025-04-30 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2025-03-27 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-03-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-25 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-06-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-31 | Jones Trading | Initiate | Buy |
| 2024-05-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2024-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-18 | Leerink Partners | Initiate | Outperform |
| 2024-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-09-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
12 analysts have analysed RGLS and the average price target is 8.67 USD. This implies a price increase of 6.25% is expected in the next year compared to the current price of 8.16.
The consensus rating for REGULUS THERAPEUTICS INC (RGLS) is 73.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.